Predicción y previsión de precio de Damora Therapeutics Inc (DMRA)DMRADamora Therapeutics Inc

Alphio's DMRA stock price prediction model matches the current Damora Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $20.86 (-1.08%). The 1-week path is $19.65 (-6.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Damora Therapeutics (DMRA) is not a good buy right now, as the current price is $18.44, which is significantly below the analyst price targets of $50 and $60. However, the stock has a low RSI of 28.91, indicating it is oversold, which could present a buying opportunity in the future. The main risk is the company's substantial net losses, with a reported net income loss of $31.17 million in Q2 2026, which raises concerns about its financial health.

Damora Therapeutics Inc (DMRA) last closed at $21.09, losing -2.86%. These facts feed the 1-day and 1-week DMRA price prediction above.